Imaging in Amyotrophic Lateral

[1]  W. Le,et al.  Genetics of amyotrophic lateral sclerosis: an update , 2013, Molecular Neurodegeneration.

[2]  M. Tosetti,et al.  High-Resolution 7T MR Imaging of the Motor Cortex in Amyotrophic Lateral Sclerosis , 2016, American Journal of Neuroradiology.

[3]  Bruce Fischl,et al.  FreeSurfer , 2012, NeuroImage.

[4]  Rainer Goebel,et al.  Analysis of functional image analysis contest (FIAC) data with brainvoyager QX: From single‐subject to cortically aligned group general linear model analysis and self‐organizing group independent component analysis , 2006, Human brain mapping.

[5]  B. Mohammadi,et al.  ALSFRS-R score and its ratio: A useful predictor for ALS-progression , 2008, Journal of the Neurological Sciences.

[6]  L. Martí-Bonmatí,et al.  Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis , 2018, Front. Neurosci..

[7]  S. Yale,et al.  Jean-Martin Charcot: The Father of Neurology , 2011, Clinical Medicine & Research.

[8]  D. Consonni,et al.  Amyotrophic lateral sclerosis: a comparison of two staging systems in a population‐based study , 2016, European journal of neurology.

[9]  M. Filippi,et al.  Multimodal structural MRI in the diagnosis of motor neuron diseases , 2017, NeuroImage: Clinical.

[10]  J. Cedarbaum,et al.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.

[11]  M. P. van den Heuvel,et al.  Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis , 2020, Neurology.

[12]  Baziel G M van Engelen,et al.  Skeletal muscle ultrasound: correlation between fibrous tissue and echo intensity. , 2009, Ultrasound in medicine & biology.

[13]  S Cluskey,et al.  Mechanisms of neurodegeneration in amyotrophic lateral sclerosis , 2001, Molecular pathology : MP.

[14]  A. Al-Chalabi,et al.  Amyotrophic lateral sclerosis: moving towards a new classification system , 2016, The Lancet Neurology.

[15]  S. Wilton,et al.  ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? , 2019, Front. Neurosci..

[16]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[17]  Jan Kassubek,et al.  Neuroimaging of motor neuron diseases , 2012, Therapeutic advances in neurological disorders.

[18]  L. Defebvre,et al.  The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review , 2016, BMC Neurology.

[19]  F. Medina-Mirapeix,et al.  Quantitative Muscle Ultrasonography Using Textural Analysis in Amyotrophic Lateral Sclerosis , 2017, Ultrasonic imaging.

[20]  A. Al-Chalabi,et al.  ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS , 2018, Neurology.

[21]  S. Pillen,et al.  Muscle changes in amyotrophic lateral sclerosis: A longitudinal ultrasonography study , 2011, Clinical Neurophysiology.

[22]  Max A. Viergever,et al.  elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.

[23]  O. Hermine,et al.  ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? , 2017, Front. Aging Neurosci..

[24]  C. Campi,et al.  Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images , 2020, EJNMMI Research.

[25]  P. Shaw,et al.  Respiratory management of motor neurone disease: a review of current practice and new developments , 2012, Practical Neurology.

[26]  L. Martí-Bonmatí,et al.  The width of the third ventricle associates with cognition and behaviour in motor neuron disease , 2018, Acta neurologica Scandinavica.

[27]  M. Cartwright,et al.  A pilot study of neuromuscular ultrasound as a biomarker for amyotrophic lateral sclerosis , 2019, Muscle & nerve.

[28]  O. Hardiman,et al.  Amyotrophic lateral sclerosis , 2011, The Lancet.

[29]  M. Swash,et al.  Lower motor neuron dysfunction in ALS , 2016, Clinical Neurophysiology.

[30]  M. Swash,et al.  Phrenic nerve stimulation is more sensitive than ultrasound measurement of diaphragm thickness in assessing early ALS progression , 2017, Neurophysiologie Clinique/Clinical Neurophysiology.

[31]  Vincent Calhoun,et al.  Data-driven approaches for identifying links between brain structure and function in health and disease , 2018, Dialogues in clinical neuroscience.

[32]  H. Heinze,et al.  Quantifying disease progression in amyotrophic lateral sclerosis using peripheral nerve sonography , 2016, Muscle & nerve.

[33]  S. Kalra.  Magnetic Resonance Spectroscopy in ALS , 2019, Front. Neurol..

[34]  G. Forster,et al.  Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS , 2003, Neurology.

[35]  R W Cox,et al.  AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. , 1996, Computers and biomedical research, an international journal.

[36]  F. Walker,et al.  Peripheral nerve and muscle ultrasound in amyotrophic lateral sclerosis , 2011, Muscle & nerve.

[37]  I. Wilkinson,et al.  Imaging muscle as a potential biomarker of denervation in motor neuron disease , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[38]  W. Bradley,et al.  Amyotrophc Lateral Sclerosis: Part 1. Clinical Features, Pathology, and E h c d Issues in Management* , 2004 .

[39]  H. Axer,et al.  Muscle ultrasonography as an additional diagnostic tool for the diagnosis of amyotrophic lateral sclerosis , 2015, Clinical Neurophysiology.

[40]  Paul Wicks,et al.  How common are ALS plateaus and reversals? , 2016, Neurology.

[41]  A. Peltier,et al.  Muscle ultrasound quantifies the rate of reduction of muscle thickness in amyotrophic lateral sclerosis , 2010, Muscle & nerve.

[42]  M. P. van den Heuvel,et al.  Cortical thickness in ALS: towards a marker for upper motor neuron involvement , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[43]  P N Leigh,et al.  Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. , 2000, Brain : a journal of neurology.

[44]  H. Heinze,et al.  Peripheral nerve ultrasound in amyotrophic lateral sclerosis phenotypes , 2015, Muscle & nerve.

[45]  Karel G M Moons,et al.  Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model , 2018, The Lancet Neurology.

[46]  J. Veldink,et al.  Subcortical structures in amyotrophic lateral sclerosis , 2015, Neurobiology of Aging.

[47]  M. Filippi,et al.  Brain MR Imaging in Patients with Lower Motor Neuron-Predominant Disease. , 2016, Radiology.

[48]  M. Filippi,et al.  The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis , 2010, American Journal of Neuroradiology.

[49]  Arno Klein,et al.  A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.

[50]  T. Hortobágyi,et al.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[51]  Z. Simmons,et al.  ULTRASOUND IN THE DIAGNOSIS AND MONITORING OF AMYOTROPHIC LATERAL SCLEROSIS: A REVIEW , 2019, Muscle & nerve.

[52]  L. H. van den Berg,et al.  The Combined Assessment of Function and Survival (CAFS): A new endpoint for ALS clinical trials , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[53]  M. Filippi,et al.  The Cortical Signature of Amyotrophic Lateral Sclerosis , 2012, PloS one.

[54]  Beatriz Luna,et al.  The nuisance of nuisance regression: Spectral misspecification in a common approach to resting-state fMRI preprocessing reintroduces noise and obscures functional connectivity , 2013, NeuroImage.

[55]  K. Byth,et al.  Rate of disease progression: a prognostic biomarker in ALS , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[56]  Maxime Sermesant,et al.  Cardiac Interventional Guidance using Multimodal Data Processing and Visualisation: medInria as an Interoperability Platform , 2012 .

[57]  M. Turner,et al.  Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[58]  Satrajit S. Ghosh,et al.  FMRIPrep: a robust preprocessing pipeline for functional MRI , 2018, bioRxiv.

[59]  A. Al-Chalabi,et al.  Comparison of the King’s and MiToS staging systems for ALS , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[60]  J. Reisch,et al.  Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis , 1998, Neurology.

[61]  P. Mcgeer,et al.  Inflammatory processes in amyotrophic lateral sclerosis , 2002, Muscle & nerve.

[62]  L. Martí-Bonmatí,et al.  Development of imaging biomarkers and generation of big data , 2017, La radiologia medica.

[63]  D. Cleveland,et al.  ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.

[64]  J. Vázquez-Costa,et al.  Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study , 2016, Journal of Neurology.

[65]  B. Mohammadi,et al.  Extent of cortical involvement in amyotrophic lateral sclerosis – an analysis based on cortical thickness , 2013, BMC Neurology.

[66]  E. Beghi,et al.  Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: A population-based study , 2006, Journal of the Neurological Sciences.

[67]  J. M. Matamala,et al.  Comparison of cross‐sectional areas and distal‐proximal nerve ratios in amyotrophic lateral sclerosis , 2018, Muscle & nerve.

[68]  P. Nestor,et al.  Toward in vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosis , 2019, Muscle & nerve.

[69]  H. Matsuda,et al.  Usefulness of SWI for the Detection of Iron in the Motor Cortex in Amyotrophic Lateral Sclerosis , 2015, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[70]  J. Ioannidis.  The Proposal to Lower P Value Thresholds to .005. , 2018, JAMA.

[71]  Karl J. Friston,et al.  Analysis of fMRI Time-Series Revisited , 1995, NeuroImage.

[72]  Yu Zhang,et al.  The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional Architecture , 2016, Cerebral cortex.

[73]  M. Swash,et al.  Ultrasound for assessment of diaphragm in ALS , 2016, Clinical Neurophysiology.

[74]  Hideto Miwa,et al.  Ultrasonography of the diaphragm in amyotrophic lateral sclerosis: Clinical significance in assessment of respiratory functions , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[75]  J P Miller,et al.  Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. , 1992, Physical therapy.

[76]  F. Medina-Mirapeix,et al.  Muscular Echovariation: A New Biomarker in Amyotrophic Lateral Sclerosis. , 2017, Ultrasound in medicine & biology.

[77]  M. E. del Baño-Aledo,et al.  Quantitative neuromuscular ultrasound analysis as biomarkers in amyotrophic lateral sclerosis , 2019, European Radiology.

[78]  L. Martí-Bonmatí,et al.  How to integrate quantitative information into imaging reports for oncologic patients. , 2018, Radiologia.

[79]  N. De Stefano,et al.  Clinical use of brain volumetry , 2013, Journal of magnetic resonance imaging : JMRI.

[80]  H. Axer,et al.  Nerve ultrasound for differentiation between amyotrophic lateral sclerosis and multifocal motor neuropathy , 2015, Journal of Neurology.

[81]  J. Vázquez-Costa,et al.  Urodynamic findings in amyotrophic lateral sclerosis patients with lower urinary tract symptoms: Results from a pilot study , 2017, Neurourology and urodynamics.

[82]  S. Pillen,et al.  Quantitative muscle ultrasonography in amyotrophic lateral sclerosis. , 2008, Ultrasound in medicine & biology.

[83]  Xiwen Sun,et al.  Age-dependent brain activation during forward and backward digit recall revealed by fMRI , 2005, NeuroImage.

[84]  Elaine Niven,et al.  Screening for cognition and behaviour changes in ALS , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[85]  H. Sawada.  Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis , 2017, Expert opinion on pharmacotherapy.

[86]  Thomas T. Liu,et al.  A component based noise correction method (CompCor) for BOLD and perfusion based fMRI , 2007, NeuroImage.

[87]  J. Glass,et al.  Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS). , 2019, JAMA neurology.

[88]  P. Shaw,et al.  Motor neurone disease: a practical update on diagnosis and management. , 2010, Clinical medicine.

[89]  M. Filippi,et al.  MR Imaging of Brachial Plexus and Limb-Girdle Muscles in Patients with Amyotrophic Lateral Sclerosis. , 2016, Radiology.

[90]  L. Roccatagliata,et al.  Detection of motor cortex thinning and corticospinal tract involvement by quantitative MRI in amyotrophic lateral sclerosis , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[91]  A. Al-Chalabi,et al.  A proposed staging system for amyotrophic lateral sclerosis , 2012, Brain : a journal of neurology.

[92]  G. Douaud,et al.  Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis , 2014, Brain : a journal of neurology.

[93]  A. L. La Spada,et al.  ALS motor phenotype heterogeneity, focality, and spread , 2009, Neurology.

[94]  Nimish J. Thakore,et al.  Stage-specific riluzole effect in amyotrophic lateral sclerosis: a retrospective study , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[95]  M. P. van den Heuvel,et al.  Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[96]  Karl J. Friston,et al.  Statistical parametric mapping , 2013 .

[97]  Michael Sendtner,et al.  Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis , 2011, Nature Reviews Neurology.

[98]  O. Ciccarelli,et al.  Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. , 2013, Academic radiology.

[99]  L. Martí-Bonmatí,et al.  Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis , 2018, Acta neurologica Scandinavica.

[100]  Ferdinand Schweser,et al.  Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study , 2012, NeuroImage.

[101]  John L.P. Thompson,et al.  Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[102]  V. Fornés-Ferrer,et al.  Sonoelastography for the Assessment of Muscle Changes in Amyotrophic Lateral Sclerosis: Results of a Pilot Study. , 2018, Ultrasound in medicine & biology.

[103]  P. Wicks,et al.  Online assessment of ALS functional rating scale compares well to in-clinic evaluation: A prospective trial , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[104]  Jeff H. Duyn,et al.  Iron Accumulation in Deep Cortical Layers Accounts for MRI Signal Abnormalities in ALS: Correlating 7 Tesla MRI and Pathology , 2012, PloS one.

[105]  S. Pillen,et al.  Muscle ultrasonography: A diagnostic tool for amyotrophic lateral sclerosis , 2012, Clinical Neurophysiology.

[106]  J. Ravits,et al.  Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants. , 2015, Neurologic clinics.

[107]  N. Makris,et al.  Decreased volume of left and total anterior insular lobule in schizophrenia , 2006, Schizophrenia Research.

[108]  M. Filippi,et al.  Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis , 2016, Neurotherapeutics.

[109]  V. Fornés-Ferrer,et al.  Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian Community. , 2020, Neurologia.

[110]  Karl J. Friston,et al.  Slice-timing effects and their correction in functional MRI , 2011, NeuroImage.

[111]  Arthur W. Toga,et al.  A Probabilistic Atlas of the Human Brain: Theory and Rationale for Its Development The International Consortium for Brain Mapping (ICBM) , 1995, NeuroImage.

[112]  Orla Hardiman,et al.  Cognitive impairment in amyotrophic lateral sclerosis , 2007, The Lancet Neurology.

[113]  A Yagishita,et al.  Location of the corticospinal tract in the internal capsule at MR imaging. , 1994, Radiology.

[114]  E. Clini,et al.  Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis , 2016, Respirology.

[115]  Iain D. Wilkinson,et al.  Biomarkers in Motor Neuron Disease: A State of the Art Review , 2019, Front. Neurol..

[116]  J. Lagopoulos,et al.  Peripheral nerve diffusion tensor imaging as a measure of disease progression in ALS , 2017, Journal of Neurology.

[117]  S. Kuwabara,et al.  Ultrasonographic detection of fasciculations markedly increases diagnostic sensitivity of ALS , 2011, Neurology.

[118]  F. Medina-Mirapeix,et al.  Monitoring Progression of Amyotrophic Lateral Sclerosis Using Ultrasound Morpho-Textural Muscle Biomarkers: A Pilot Study. , 2018, Ultrasound in medicine & biology.

[119]  M. Swash,et al.  Electrodiagnostic criteria for diagnosis of ALS , 2008, Clinical Neurophysiology.

[120]  N. Staff,et al.  Magnetic resonance imaging abnormalities of peripheral nerve and muscle are common in amyotrophic lateral sclerosis and share features with multifocal motor neuropathy , 2015, Muscle & nerve.

[121]  Wei Li,et al.  Susceptibility‐weighted imaging and quantitative susceptibility mapping in the brain , 2015, Journal of magnetic resonance imaging : JMRI.

[122]  Susan L. Whitfield-Gabrieli,et al.  Conn: A Functional Connectivity Toolbox for Correlated and Anticorrelated Brain Networks , 2012, Brain Connect..

[123]  D. Schoenfeld,et al.  Quantitative strength testing in ALS clinical trials , 2016, Neurology.

[124]  Timothy S. Coalson,et al.  Parcellations and hemispheric asymmetries of human cerebral cortex analyzed on surface-based atlases. , 2012, Cerebral cortex.

[125]  L. Greensmith,et al.  Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity , 2018, Neurology.

[126]  David C. Van Essen,et al.  Human Connectome Project , 2014, Encyclopedia of Computational Neuroscience.

[127]  C. Elger,et al.  Laboratory markers of cardiac and metabolic complications after generalized tonic-clonic seizures , 2017, BMC Neurology.

[128]  R. Henry,et al.  Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. , 2007, Archives of neurology.

[129]  W. Robberecht,et al.  The phenotypic variability of amyotrophic lateral sclerosis , 2014, Nature Reviews Neurology.

[130]  Mark W. Woolrich,et al.  Bayesian analysis of neuroimaging data in FSL , 2009, NeuroImage.

[131]  I. Wilkinson,et al.  Longitudinal multi-modal muscle-based biomarker assessment in motor neuron disease , 2019, Journal of Neurology.

[132]  D. Burke,et al.  Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[133]  Zhi-rui Zhou,et al.  Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2017, Journal of Neurology, Neurosurgery & Psychiatry.

[134]  Andriy Fedorov,et al.  Computational Radiomics System to Decode the Radiographic Phenotype. , 2017, Cancer research.

[135]  M. de Carvalho,et al.  SVC Is a Marker of Respiratory Decline Function, Similar to FVC, in Patients With ALS , 2019, Front. Neurol..

[136]  S. Teipel,et al.  Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study , 2013, Journal of Neurology.

[137]  V. Fornés-Ferrer,et al.  New insights into the pathophysiology of fasciculations in amyotrophic lateral sclerosis: An ultrasound study , 2018, Clinical Neurophysiology.

[138]  S. Pillen,et al.  Muscle ultrasonography to predict survival in amyotrophic lateral sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[139]  Marisa O. Hollinshead,et al.  Identification of common variants associated with human hippocampal and intracranial volumes , 2012, Nature Genetics.

[140]  R. Kaji,et al.  Thinning of cervical nerve roots and peripheral nerves in ALS as measured by sonography , 2014, Clinical Neurophysiology.

[141]  V. Fornés-Ferrer,et al.  Genetic and constitutional factors are major contributors to substantia nigra hyperechogenicity , 2017, Scientific Reports.

[142]  O. Hardiman,et al.  Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics , 2017, BMC Neurology.

[143]  S. Vielhaber,et al.  Peripheral nerve imaging in amyotrophic lateral sclerosis , 2020, Clinical Neurophysiology.